文献速递神经肿瘤

人胶质瘤中的FGFR-TACC基因融合

FGFR-TACC gene fusions in human glioma.
PubMed 文献 · Neuro Oncol · 2017-01-01

本文综述了在人多形性胶质母细胞瘤(GBM)及其他癌种中发现的FGFR-TACC基因融合,讨论其赋予异柠檬酸脱氢酶野生型胶质瘤细胞的独特生物学与临床特征。FGFR-TACC融合产生强效癌基因,兼具促生长与导致非整倍体的作用,是克隆性肿瘤起始事件,对FGFR酪氨酸激酶抑制剂高度敏感。已有筛选方法可准确识别融合变异,早期临床数据显示对携带融合且接受FGFR抑制剂治疗的患者有初步疗效。

要点

  • FGFR-TACC融合是克隆性肿瘤起始事件,对FGFR酪氨酸激酶抑制剂高度敏感。
  • 融合癌基因兼具促生长与非整倍体诱导效应,细胞内信号机制尚不明确。
  • 已报道可准确识别FGFR-TACC融合变异的筛选方法,早期临床数据有初步疗效。

核心结论

  • FGFR-TACC基因融合为在人GBM中验证精准医学范式提供了「低垂果实」模型。

研究设计与样本

  • 综述,回顾FGFR-TACC基因融合在人类胶质瘤中的研究进展。

主要发现

  • FGFR-TACC融合首见于人多形性胶质母细胞瘤(GBM),后见于多种其他癌种。
  • FGFR-TACC融合产生强效癌基因,兼具促生长效应与非整倍体诱导,细胞内信号机制尚不明确。
  • FGFR-TACC融合是克隆性肿瘤起始事件,对FGFR酪氨酸激酶抑制剂高度敏感。
  • 已报道可准确识别人类癌症中FGFR-TACC融合变异的筛选方法。
  • 早期临床数据显示携带FGFR-TACC融合并接受FGFR抑制剂治疗的患者有初步疗效。

临床怎么用

  • 作者认为FGFR-TACC基因融合可作为在人GBM中验证精准医学范式的模型。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chromosomal translocations joining in-frame members of the fibroblast growth factor receptor-transforming acidic coiled-coil gene families (the FGFR-TACC gene fusions) were first discovered in human glioblastoma multiforme (GBM) and later in many other cancer types. Here, we review this rapidly expanding field of research and discuss the unique biological and clinical features conferred to isocitrate dehydrogenase wild-type glioma cells by FGFR-TACC fusions. FGFR-TACC fusions generate powerful oncogenes that combine growth-promoting effects with aneuploidy through the activation of as yet unclear intracellular signaling mechanisms. FGFR-TACC fusions appear to be clonal tumor-initiating events that confer strong sensitivity to FGFR tyrosine kinase inhibitors. Screening assays have recently been reported for the accurate identification of FGFR-TACC fusion variants in human cancer, and early clinical data have shown promising effects in cancer patients harboring FGFR-TACC fusions and treated with FGFR inhibitors. Thus, FGFR-TACC gene fusions provide a "low-hanging fruit" model for the validation of precision medicine paradigms in human GBM.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Lasorella A, Sanson M, Iavarone A, et al. FGFR-TACC gene fusions in human glioma. Neuro Oncol. 2017. PMID: 27852792. doi:10.1093/neuonc/now240

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。